Skip to content

Green Tea, High in Epigallocatechin Gallate (EGCG) and Postprandial Fat Oxidation

Effects of the Green Tea Extract TEAVIGO High in EGCG, on Postprandial Fat Oxidation in Overweight Volunteers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00867555
Enrollment
24
Registered
2009-03-24
Start date
2008-10-31
Completion date
2009-05-31
Last updated
2009-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Type 2 Diabetes Mellitus

Brief summary

The body of evidence regarding the health benefits of green tea has grown considerably during the last decade and includes antioxidant properties, anti- cancer, anti-obesity and anti-diabetes effects. There has been evidence that green tea extract favorably affect body weight and body fat and has positive effects on blood glucose control Aim of this study is to investigate the short term effect (3-day)of TEAVIGO (high in the catechin EGCG) on postprandial fat oxidation during different phases of the postprandial period in overweight subjects. Secondly, in a subset of volunteers changes in lipolysis and glucose metabolism will be studied in skeletal muscle and adipose tissue.

Interventions

DIETARY_SUPPLEMENTEffect of the green tea extract TEAVIGO, high in EGCG, on postprandial fat oxidation

green tea extract TEAVIGO, high in EGCG

Sponsors

DSM Nutritional Products, Inc.
CollaboratorINDUSTRY
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 20 and 50 y * BMI 25.0-29.9 kg/m2 * Normal fasting glucose \<6.1 mmol/L * Blood pressure (systolic blood pressure 100-150 mmHg, diastolic blood pressure 60-90 mmHg) * Weight stable in last 3 months (±2 kg)

Exclusion criteria

* pregnant, lactating or (post)menopausal women * regular smokers * people with intensive fitness training eg athletes * habitual consumption of green or black tea (more than 1 or 2 cups a day, respectively) * not more than 300 mg/day caffeine consumption

Design outcomes

Primary

MeasureTime frame
postprandial fat oxidation8 months

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026